However, the link between BPA and CD36 expression has been determined in non-alcoholic fatty liver disease (NAFLD), which BPA increases hepatic lipid uptake by stimulating ROS-induced CD36 overexpression [94]. Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.